Anyone have more information on this please?
From http://www.live-pr.com/en/print1048416959.htm
7 Delivery platform: other insulin delivery routes
7.1 Delivery technology: buccal insulin delivery
7.1.1 Case Study: Oral-lyn buccal spray (Generex)
7.1.2 Case Study: Oral spray (Hubei Huagong Biochemical Engineering)
7.2 Delivery technology: oral insulin
7.2.1 Case study: Oral insulin cobalamin-coated nanoparticles (Access Pharmaceuticals)
7.2.2 Case Study: Oral insulin (Emisphere Technologies)
7.2.3 Case Study: Oradel (Apollo Life Sciences)
7.3 Delivery Technology: transdermal insulin delivery
7.3.1 Case Study: ALT 1391 (Altea Therapeutics)
7.3.2 Case Study: TPM-02/insulin (Phosphagenics)
7.3.3 Case Study: ViaDerm (TransPharma)
7.4 Delivery technology: nasal insulin administration
7.4.1 Case Study: CPE-215 (Bentley Pharmaceuticals)
7.5 Our opinion on buccal, oral, transdermal and nasal insulin delivery routes
once a week insulin drug, page-18
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(25.0%) |
Mkt cap ! $7.923M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $2.036K | 678.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 40284733 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 39213243 | 30 |
View Market Depth
| Last trade - 14.26pm 13/11/2024 (20 minute delay) ? |
| AVE (ASX) Chart |